Cleveland Diagnostics is teaming up with ZERO Prostate Cancer to help more men and their families start conversations about prostate cancer risk and screening for Prostate Cancer Awareness Month.
Public source
Publisher name
Public post
Prostate Cancer Awareness Month is here, and so is our 4th annual PSA on PSA campaign. This September, we’re excited to team up with ZERO Prostate Cancer again to help m…
Company
Cleveland Diagnostics
Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of cancer detection
- Location
- Cleveland, US
- Company size
- 51–200 employees
About Cleveland Diagnostics
Cleveland Diagnostics has unlocked the diagnostic power of protein structure with its revolutionary IsoClear™ platform to develop novel diagnostics based on protein structure-based assessment.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Partnerships
ZERO Prostate Cancer
ZERO Prostate Cancer recognized Quest Diagnostics for its partnership on ZERO's screening and education programs.
Products & Services
mdxhealth
mdxhealth supports prostate cancer care with diagnostic insights designed to guide care at key decision points along the prostate cancer journey.
Partnerships
Natera
Natera announced a national partnership with Susan G. Komen to sponsor the 2026 Premier National Series events.
Products & Services
GoPath Diagnostics
GoPath Diagnostics launched ProstateNow, a prostate-focused germline test designed to assess prognosis, therapeutic options, and inherited risk in patients and high-risk families.
Products & Services
Myriad Genetics